119 related articles for article (PubMed ID: 33195829)
1. A case of type 1 facioscapulohumeral muscular dystrophy (FSHD) with restrictive ventilatory defect and congestive heart failure.
Morimoto N; Morimoto M; Takahashi Y; Takamiya M; Nishino I; Abe K
eNeurologicalSci; 2020 Dec; 21():100284. PubMed ID: 33195829
[TBL] [Abstract][Full Text] [Related]
2. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of respiratory function in facioscapulohumeral muscular dystrophy.
Teeselink S; Vincenten SCC; Voermans NC; Groothuis JT; Doorduin J; Wijkstra PJ; Horlings CGC; van Engelen BGM; Mul K
J Neurol; 2022 Jul; 269(7):3682-3689. PubMed ID: 35147730
[TBL] [Abstract][Full Text] [Related]
4. Facioscapulohumeral muscular dystrophy and respiratory failure; what about the diaphragm?
Hazenberg A; van Alfen N; Voet NB; Kerstjens HA; Wijkstra PJ
Respir Med Case Rep; 2015; 14():37-9. PubMed ID: 26029575
[TBL] [Abstract][Full Text] [Related]
5. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction.
Turki A; Hayot M; Carnac G; Pillard F; Passerieux E; Bommart S; Raynaud de Mauverger E; Hugon G; Pincemail J; Pietri S; Lambert K; Belayew A; Vassetzky Y; Juntas Morales R; Mercier J; Laoudj-Chenivesse D
Free Radic Biol Med; 2012 Sep; 53(5):1068-79. PubMed ID: 22796148
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of facioscapulohumeral muscular dystrophy (FSHD).
Fisher J; Upadhyaya M
Neuromuscul Disord; 1997 Jan; 7(1):55-62. PubMed ID: 9132141
[TBL] [Abstract][Full Text] [Related]
7. Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy.
Moreira S; Wood L; Smith D; Marini-Bettolo C; Guglieri M; McMacken G; Bailey G; Mayhew A; Muni-Lofra R; Eglon G; Williams M; Straub V; Lochmüller H; Evangelista T
J Neurol; 2017 Jun; 264(6):1271-1280. PubMed ID: 28550484
[TBL] [Abstract][Full Text] [Related]
8. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD).
Ducharme-Smith A; Nicolau S; Chahal CAA; Ducharme-Smith K; Rehman S; Jaliparthy K; Khan N; Scott CG; St Louis EK; Liewluck T; Somers VK; Lin G; Brady PA; Milone M
Front Neurol; 2021; 12():668180. PubMed ID: 34108930
[No Abstract] [Full Text] [Related]
10. The strength and functional performance in patients with facioscapulohumeral muscular dystrophy.
Lue YJ; Chen SS
Kaohsiung J Med Sci; 2000 May; 16(5):248-54. PubMed ID: 10969520
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.
Attarian S; Salort-Campana E; Nguyen K; Behin A; Andoni Urtizberea J
Rev Neurol (Paris); 2012 Dec; 168(12):910-8. PubMed ID: 22551571
[TBL] [Abstract][Full Text] [Related]
12. A Pediatric Review of Facioscapulohumeral Muscular Dystrophy.
Mah JK; Chen YW
J Pediatr Neurol; 2018 Aug; 16(4):222-231. PubMed ID: 30923442
[TBL] [Abstract][Full Text] [Related]
13. Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era.
Zampatti S; Colantoni L; Strafella C; Galota RM; Caputo V; Campoli G; Pagliaroli G; Carboni S; Mela J; Peconi C; Gambardella S; Cascella R; Giardina E
Neurogenetics; 2019 May; 20(2):57-64. PubMed ID: 30911870
[TBL] [Abstract][Full Text] [Related]
14. [Facioscapulohumeral muscular dystrophy type 2].
Sacconi S; Desnuelle C
Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
[TBL] [Abstract][Full Text] [Related]
15. Orofacial Muscle Weakening in Facioscapulohumeral Muscular Dystrophy (FSHD) Patients.
Konstantonis D; Kekou K; Papaefthymiou P; Vastardis H; Konstantoni N; Athanasiou M; Svingou M; Margariti A; Panousopoulou A
Children (Basel); 2022 Jan; 9(1):. PubMed ID: 35053721
[TBL] [Abstract][Full Text] [Related]
16. Facioscapulohumeral muscular dystrophy.
Tawil R
Handb Clin Neurol; 2018; 148():541-548. PubMed ID: 29478599
[TBL] [Abstract][Full Text] [Related]
17. Facioscapulohumeral muscular dystrophy presenting with hypertrophic cardiomyopathy: a case study.
Tsuji M; Kinoshita M; Imai Y; Kawamoto M; Kohara N
Neuromuscul Disord; 2009 Feb; 19(2):140-2. PubMed ID: 19147353
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in facioscapulohumeral muscular dystrophy].
Hayashi YK; Goto K; Nishio I
Rinsho Shinkeigaku; 2012; 52(11):1154-7. PubMed ID: 23196547
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
20. Genotype and phenotype analysis of 43 Iranian facioscapulohumeral muscular dystrophy patients; Evidence for anticipation.
Alavi A; Esmaeili S; Nafissi S; Kahrizi K; Najmabadi H
Neuromuscul Disord; 2018 Apr; 28(4):303-314. PubMed ID: 29402602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
